CAAS Capital Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,000
Closed -$503K 562
2022
Q4
$503K Buy
+26,000
New +$503K 0.03% 184
2021
Q4
Sell
-15,000
Closed -$705K 718
2021
Q3
$705K Hold
15,000
0.01% 287
2021
Q2
$904K Buy
+15,000
New +$904K 0.02% 317